Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.6 INR | -1.10% | +0.40% | -16.22% |
Business Summary
Number of employees: 555
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Drugs & Formulations
87.9
%
| 2,195 | 94.8 % | 2,100 | 87.9 % | -4.36% |
Trading of Commodities
10.7
%
| 94 | 4.1 % | 255 | 10.7 % | +170.86% |
Renting of Property
1.4
%
| 27 | 1.2 % | 34 | 1.4 % | +24.85% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 2,317 | 100.0 % | 2,389 | 100.0 % | +3.11% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 65 | 21/88/21 | |
Director of Finance/CFO | - | 01/14/01 | |
Vaishali Agrawal
CMP | Compliance Officer | - | 03/23/03 |
Sales & Marketing | - | 12/16/12 | |
Payal Bankda
HRO | Human Resources Officer | - | 01/11/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 21/88/21 | |
Founder | 65 | 21/88/21 | |
Director/Board Member | 37 | 15/17/15 | |
Ruchi Jindal
BRD | Director/Board Member | - | 28/22/28 |
Director/Board Member | 49 | 14/23/14 | |
Ankit Jain
BRD | Director/Board Member | 37 | 14/23/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 940,000,000 | 463,277,376 ( 49.28 %) | 0 | 49.28 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
83,061,125 | 8.84% | 11,920,933 $ |
Company contact information
Syncom Formulations (India) Ltd.
207, Saket Nagar
452018, Indore
+91 73 1270 0458
http://www.syncomformulations.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-16.22% | 14Cr | |
+55.19% | 81TCr | |
+47.26% | 65TCr | |
-6.09% | 35TCr | |
+21.92% | 34TCr | |
+18.40% | 25TCr | |
+3.64% | 23TCr | |
+12.98% | 22TCr | |
+10.86% | 17TCr | |
-2.78% | 16TCr |
- Stock Market
- Equities
- SYNCOMF Stock
- Company Syncom Formulations (India) Limited